Last reviewed · How we verify
Arteriovenous conduit implant
At a glance
| Generic name | Arteriovenous conduit implant |
|---|---|
| Sponsor | Vascudyne, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis (PHASE3)
- Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study) (PHASE1, PHASE2)
- Trial of Fistula Versus Graft in Elderly Patients (NA)
- BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial (PHASE3)
- Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Arteriovenous conduit implant CI brief — competitive landscape report
- Arteriovenous conduit implant updates RSS · CI watch RSS
- Vascudyne, Inc. portfolio CI